Benzeneethanamine, α-methyl-3-(trifluoromethyl)-, (αS)-
| Title | Journal |
|---|---|
| [Letter on the article: 'benfluorex and valvular heart disease']. | Presse medicale (Paris, France : 1983) 20120301 |
| Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class. | Bioorganic & medicinal chemistry 20111201 |
| [Benfluorex and valvular heart disease]. | Presse medicale (Paris, France : 1983) 20111101 |
| Pharmacokinetic properties of N-nitrosofenfluramine after its administration to rats. | Biomedical chromatography : BMC 20110501 |
| Organ culture as a tool to identify early mechanisms of serotonergic valve disease. | The Journal of heart valve disease 20100901 |
| Appetite suppressants, cardiac valve disease and combination pharmacotherapy. | American journal of therapeutics 20090101 |
| Serotonergic responses in depressed patients with or without a history of alcohol use disorders and healthy controls. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080901 |
| Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. | Journal of medicinal chemistry 20080124 |
| The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine. | Bioorganic & medicinal chemistry 20071101 |
| The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension. | The Journal of pharmacology and experimental therapeutics 20070501 |
| Elevated childhood serotonergic function protects against adolescent aggression in disruptive boys. | Journal of the American Academy of Child and Adolescent Psychiatry 20060701 |
| Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity. | Molecular interventions 20051001 |
| (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter. | The Journal of pharmacology and experimental therapeutics 20050901 |
| Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor. | Molecular pharmacology 20050701 |
| Hair analysis for fenfluramine and norfenfluramine as biomarkers for N-nitrosofenfluramine ingestion. | Forensic science international 20041110 |
| The fenfluramine metabolite (+)-norfenfluramine is vasoactive. | The Journal of pharmacology and experimental therapeutics 20040501 |
| Nordexfenfluramine causes more severe pulmonary vasoconstriction than dexfenfluramine. | American journal of physiology. Lung cellular and molecular physiology 20040301 |
| Relationship between anorexia and loss of serotonin uptake sites in brain of mice and rats receiving d-norfenfluramine or d-fenfluramine. | Pharmacology, biochemistry, and behavior 20040301 |
| The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. | Journal of thrombosis and haemostasis : JTH 20031201 |
| (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. | The Journal of pharmacology and experimental therapeutics 20030601 |
| 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. | Molecular pharmacology 20030601 |
| Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs. | Brain research 20020927 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Saccadic peak velocity and EEG as end-points for a serotonergic challenge test. | Human psychopharmacology 20020301 |
| Fluorometric determination of DL-fenfluramine, DL-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography. | Journal of chromatography. B, Biomedical sciences and applications 20011105 |
| Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. | Neuropharmacology 20010801 |
| Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. | Circulation 20001205 |
| Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. | Molecular pharmacology 20000101 |
| Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential. | Pharmacology, biochemistry, and behavior 19980301 |
| d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors. | European journal of pharmacology 19930921 |
| Fenfluramine treatment of twenty children with autism. | Journal of autism and developmental disorders 19891201 |
| Long-term efficacy of fenfluramine in treatment of obesity. | Lancet (London, England) 19830219 |